SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Rudd who wrote (13822)2/2/2002 7:56:07 PM
From: Madharry  Read Replies (1) of 78774
 
I am glad you made moneywith ELN but this type of accounting just stinks and it makes me wonder what other problems they are having. Clearly much of the revenue is phony. Unfortunately it seems to me that time and time again when companies start pulling accounting shenanigans there are serious problems with the business fundamentals under the circumstances how do you say "its not worth 40 but it is worth mid 20s". We have seen lots of dishonesty and poor dilligence with these drug companies as well. On another thread we had some lengthy discussions about IMCL. There are smart biotech people who have bought that one at 18 and some of those bought ELN at 25 or less but so far I cant think of any situations where highly suspect accounting has been overcome by terrific operatiing results of a company.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News